Pricing Log in Create free account

Climb Bio, Inc. (CLYM) vs Valneva SE Sponsored ADR (VALN)

Climb Bio, Inc. and Valneva SE Sponsored ADR are both Biotechnology companies. Climb Bio, Inc. and Valneva SE Sponsored ADR are of similar size ($536.5M and $509.5M). Climb Bio, Inc. has negative trailing earnings, so its P/E is not meaningful; Valneva SE Sponsored ADR trades at 59.3×. Climb Bio, Inc. has the higher net margin (0.00% vs −12.0%) and the lower return on invested capital (−71.7% vs 0.00%). Across the 12 metrics below, Climb Bio, Inc. leads on 6 and Valneva SE Sponsored ADR on 6.

Valuation

Metric CLYM VALN Biotechnology median
P/E n/m 59.26 10.60
P/S n/m 3.02 9.40
P/B 3.27 5.26 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m 42.64 0.66
EV/Sales n/m 3.47 9.02
Earnings yield (8.07%) 1.69% (32.88%)
Free cash flow yield (6.79%) (11.87%) (23.13%)

Profitability

Metric CLYM VALN Biotechnology median
Gross margin — 38.28% 68.51%
Operating margin 0.00% 13.56% 0.00%
Net margin 0.00% (12.01%) 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (27.10%) 0.00% (51.96%)
Return on assets (26.27%) 0.00% (46.06%)
Return on invested capital (71.73%) 0.00% 0.00%

Growth

Metric CLYM VALN Biotechnology median
Revenue growth (TTM) — (53.16%) 6.76%
EPS growth (last fiscal year) 42.48% (805.88%) 29.88%
Revenue growth, 5-year CAGR — 9.41% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CLYM VALN Biotechnology median
Debt to equity 0.00 2.27 0.00
Current ratio 31.45 2.16 4.97
Net debt to EBITDA 1.44 (1.15) 1.01

Dividend

Metric CLYM VALN Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CLYM VALN Biotechnology median
Market cap 509.46m 536.53m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack